BDBM403427 2-(5-((1aS,8R,8aR)-4-fluoro-8-(2-(pyridin-4-ylmethoxy)phenyl)-1,1a,8,8a-tetrahydrobenzo[d]cyclopropa[3,4]pyrrolo[1,2-a]imidazol-5-yl)pyrimidin-2-yl)propan-2-ol and 2-(5-((1aS,8S,8aR)-4-fluoro-8-(2-(pyridin-4-ylmethoxy)phenyl)-1,1a,8,8a-tetrahydrobenzo[d]cyclopropa[3,4]pyrrolo[1,2-a]imidazol-5-yl)pyrimidin-2-yl)propan-2-ol::US10335392, Example 34

SMILES CC(C)(O)c1ncc(cn1)-c1cc2n3[C@H]([C@@H]4C[C@@H]4c3nc2cc1F)c1ccccc1OCc1ccncc1

InChI Key InChIKey=SMBWSTQAPWTKBN-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 403427   

TargetTumor necrosis factor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM403427(US10335392, Example 34 | 2-(5-((1aS,8R,8aR)-4-fluo...)
Affinity DataIC50: 5.50E+3nMAssay Description:Test compounds serially diluted in DMSO were plated in an assay plate (LABCYTE, Cat. # LP-0200) at final concentrations ranging from 0.004 μM to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
Go to US Patent